NASDAQ:NEOS - Neos Therapeutics News Headlines

Sign in or create an account to add this stock to your watchlist.
$3.14 +0.22 (+7.53 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$2.92
Today's Range$2.91 - $3.21
52-Week Range$1.40 - $9.20
Volume749,772 shs
Average Volume414,554 shs
Market Capitalization$93.20 million
P/E Ratio-1.96
Dividend YieldN/A
Beta0.96

Headlines

Neos Therapeutics (NASDAQ NEOS) News Headlines

Source:
DateHeadline
Edited Transcript of NEOS earnings conference call or presentation 14-Mar-19 12:30pm GMTEdited Transcript of NEOS earnings conference call or presentation 14-Mar-19 12:30pm GMT
finance.yahoo.com - March 15 at 10:59 AM
Neos Therapeutics (NEOS) Issues  Earnings ResultsNeos Therapeutics (NEOS) Issues Earnings Results
www.americanbankingnews.com - March 15 at 8:56 AM
Neos Therapeutics, Inc. (NEOS) CEO Jerry McLaughlin on Q4 2018 Results - Earnings Call TranscriptNeos Therapeutics, Inc. (NEOS) CEO Jerry McLaughlin on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 14 at 5:21 PM
Neos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial ResultsNeos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
www.globenewswire.com - March 14 at 11:03 AM
NEOS Earnings DateNEOS Earnings Date
www.nasdaq.com - March 14 at 11:03 AM
Neos Therapeutics: 4Q Earnings SnapshotNeos Therapeutics: 4Q Earnings Snapshot
finance.yahoo.com - March 14 at 11:03 AM
Neos Therapeutics (NEOS) Scheduled to Post Quarterly Earnings on ThursdayNeos Therapeutics (NEOS) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - March 8 at 8:57 AM
Neos Therapeutics to Host Fourth Quarter and Year-End 2018 Financial and Operating Results Conference Call on March 14th, 2019Neos Therapeutics to Host Fourth Quarter and Year-End 2018 Financial and Operating Results Conference Call on March 14th, 2019
finance.yahoo.com - March 7 at 11:24 AM
Neos Therapeutics Inc (NEOS) Given Consensus Recommendation of "Buy" by BrokeragesNeos Therapeutics Inc (NEOS) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 26 at 1:46 AM
Neos Therapeutics Announces Appointment of James Robinson to Board of DirectorsNeos Therapeutics Announces Appointment of James Robinson to Board of Directors
finance.yahoo.com - January 30 at 10:03 AM
Form SC 13G Neos Therapeutics, Inc. Filed by: Broadfin Capital, LLC - StreetInsider.comForm SC 13G Neos Therapeutics, Inc. Filed by: Broadfin Capital, LLC - StreetInsider.com
www.streetinsider.com - January 5 at 4:51 PM
North Texas biotech settles litigation over ADHD drugNorth Texas biotech settles litigation over ADHD drug
www.bizjournals.com - December 27 at 4:55 PM
Teva Stock Rises on Patent Settlement With Neos TherapeuticsTeva Stock Rises on Patent Settlement With Neos Therapeutics
www.zacks.com - December 27 at 9:16 AM
Neos Therapeutics settles Cotempla XR-ODT patent litigation with TevaNeos Therapeutics settles Cotempla XR-ODT patent litigation with Teva
seekingalpha.com - December 26 at 4:58 PM
Neos, Teva settle litigation over ADHD drugNeos, Teva settle litigation over ADHD drug
www.bizjournals.com - December 26 at 4:58 PM
Teva shares surge 5% on news of patent settlement with Neos over ADHD drugTeva shares surge 5% on news of patent settlement with Neos over ADHD drug
www.marketwatch.com - December 26 at 3:34 PM
Neos Reaches Settlement With Teva On Cotempla XR-ODT Patent LitigationNeos Reaches Settlement With Teva On Cotempla XR-ODT Patent Litigation
www.nasdaq.com - December 26 at 9:11 AM
BRIEF-Neos Therapeutics Announces Settlement With Teva On Cotempla Xr-Odt Patent LitigationBRIEF-Neos Therapeutics Announces Settlement With Teva On Cotempla Xr-Odt Patent Litigation
www.msn.com - December 26 at 9:11 AM
Neos Therapeutics Announces Settlement with Teva on Cotempla XR-ODT® Patent LitigationNeos Therapeutics Announces Settlement with Teva on Cotempla XR-ODT® Patent Litigation
www.nasdaq.com - December 26 at 9:11 AM
Teva +2% after patent settlement with Neos TherapeuticsTeva +2% after patent settlement with Neos Therapeutics
seekingalpha.com - December 26 at 9:11 AM
Neos Therapeutics Inc.Neos Therapeutics Inc.
www.barrons.com - December 11 at 4:54 PM
Neos Therapeutics Announces Realignment of Commercial Organization - GlobeNewswireNeos Therapeutics Announces Realignment of Commercial Organization - GlobeNewswire
globenewswire.com - December 2 at 8:44 AM
Neos Therapeutics (NEOS) Reports Realignment of Commercial OrganizationNeos Therapeutics (NEOS) Reports Realignment of Commercial Organization
www.streetinsider.com - November 30 at 5:24 PM
BRIEF-Neos Therapeutics Inc - Approved A Plan To Realign Its SalesforceBRIEF-Neos Therapeutics Inc - Approved A Plan To Realign Its Salesforce
www.msn.com - November 30 at 9:16 AM
BRIEF-Neos Therapeutics - Approved Realignment Of Cos Commercial OrganizationBRIEF-Neos Therapeutics - Approved Realignment Of Co's Commercial Organization
www.msn.com - November 30 at 9:16 AM
Neos Therapeutics Announces Realignment of Commercial OrganizationNeos Therapeutics Announces Realignment of Commercial Organization
finance.yahoo.com - November 30 at 9:16 AM
Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive OfficerAltimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer
finance.yahoo.com - November 27 at 9:32 AM
Neos Therapeutics: The Road AheadNeos Therapeutics: The Road Ahead
seekingalpha.com - November 14 at 4:49 PM
Edited Transcript of NEOS earnings conference call or presentation 9-Nov-18 1:30pm GMTEdited Transcript of NEOS earnings conference call or presentation 9-Nov-18 1:30pm GMT
finance.yahoo.com - November 10 at 9:05 AM
Neos Therapeutics Q3 revenues up 76%Neos Therapeutics Q3 revenues up 76%
seekingalpha.com - November 9 at 9:24 AM
Neos Therapeutics Reports Third Quarter 2018 Financial ResultsNeos Therapeutics Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 9 at 9:24 AM
Neos Therapeutics: 3Q Earnings SnapshotNeos Therapeutics: 3Q Earnings Snapshot
finance.yahoo.com - November 9 at 9:24 AM
Neos Therapeutics (NEOS) Reports Q3 Loss, Lags Revenue EstimatesNeos Therapeutics (NEOS) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 9 at 9:24 AM
Neos Therapeutics (NEOS) Plans Offering of Common StockNeos Therapeutics (NEOS) Plans Offering of Common Stock
www.streetinsider.com - November 6 at 8:57 AM
Neos Therapeutics Announces Proposed Offering of Common StockNeos Therapeutics Announces Proposed Offering of Common Stock
finance.yahoo.com - November 5 at 4:55 PM
Neos Therapeutics to Host Third Quarter 2018 Financial Results Conference Call on November 9, 2018Neos Therapeutics to Host Third Quarter 2018 Financial Results Conference Call on November 9, 2018
finance.yahoo.com - November 2 at 9:45 AM
How Is Johnson & Johnson’s Neuroscience Business Positioned?How Is Johnson & Johnson’s Neuroscience Business Positioned?
finance.yahoo.com - October 25 at 4:52 PM
Neos Therapeutics to Present New Data for ADHD Medication, Adzenys XR-ODT®, at the American Academy of Child & Adolescent Psychiatry MeetingNeos Therapeutics to Present New Data for ADHD Medication, Adzenys XR-ODT®, at the American Academy of Child & Adolescent Psychiatry Meeting
finance.yahoo.com - October 24 at 8:39 AM
Neos Therapeutics in-licenses excessive salivation candidate from NeuRx Pharma; shares up 2%Neos Therapeutics in-licenses excessive salivation candidate from NeuRx Pharma; shares up 2%
seekingalpha.com - October 23 at 4:52 PM
Neos Therapeutics Licenses Pipeline Candidate for Treatment of Sialorrhea (Excessive Drooling)Neos Therapeutics Licenses Pipeline Candidate for Treatment of Sialorrhea (Excessive Drooling)
finance.yahoo.com - October 23 at 8:56 AM
The Daily Biotech Pulse: Affimeds Cancer Drug Placed On Clinical Hold, Celgenes Positive Scalp Psoriasis TrialThe Daily Biotech Pulse: Affimed's Cancer Drug Placed On Clinical Hold, Celgene's Positive Scalp Psoriasis Trial
www.benzinga.com - October 9 at 8:24 AM
Neos Therapeutics to Present at the Cantor Global Healthcare ConferenceNeos Therapeutics to Present at the Cantor Global Healthcare Conference
finance.yahoo.com - September 26 at 9:01 AM
The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer SharesThe Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares
www.benzinga.com - September 18 at 8:55 AM
Neos Therapeutics to Present at the Wells Fargo Healthcare ConferenceNeos Therapeutics to Present at the Wells Fargo Healthcare Conference
finance.yahoo.com - August 29 at 8:46 AM
Edited Transcript of NEOS earnings conference call or presentation 8-Aug-18 12:30pm GMTEdited Transcript of NEOS earnings conference call or presentation 8-Aug-18 12:30pm GMT
finance.yahoo.com - August 14 at 4:56 PM
Neos Therapeutics: Growth Story Remains IntactNeos Therapeutics: Growth Story Remains Intact
seekingalpha.com - August 10 at 4:52 PM
Neos Therapeutics (NEOS) CEO Jerry McLaughlin on Q2 2018 Results - Earnings Call TranscriptNeos Therapeutics' (NEOS) CEO Jerry McLaughlin on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 4:57 PM
Neos Therapeutics: 2Q Earnings SnapshotNeos Therapeutics: 2Q Earnings Snapshot
finance.yahoo.com - August 8 at 4:57 PM
Neos Therapeutics (NEOS) Reports Q2 Loss, Lags Revenue EstimatesNeos Therapeutics (NEOS) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 8 at 4:57 PM
Neos Therapeutics Reports Second Quarter 2018 Financial ResultsNeos Therapeutics Reports Second Quarter 2018 Financial Results
finance.yahoo.com - August 8 at 8:57 AM
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Featured Article: Net Income

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel